Quality control of residual solvent content in polymeric microparticles

References

• Aftabroushad S, Doelker E. Factors influencing the entrapment of a water soluble model drug into injectable microparticles prepared using solvent evaporation and phase separation techniques. Eur J Pharm Biopharm, 1994;40:237–42
   Web of Science ®Google Scholar
• Bergsma JE. Late degradation tissue response to poly(L-lactide) bone plates and screws. Biomaterials, 1995;16(1):25–31
   PubMed Web of Science ®Google Scholar
• B’Hymer C. Residual solvent testing: A review of gas chromatographic and alternative techniques. Pharm Res, 2003;20:337–43
   PubMed Web of Science ®Google Scholar
• Bouissou C, Rouse JJ, Price R, Van der Walle CF. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharm Res, 2006;23:1295–305
   PubMed Web of Science ®Google Scholar
• Camarasu C. Unknown residual solvents – Identification in drug products by headspace solid phase microextraction gas chromatography and mass spectroscopy. Chromatographia, 2002;56:S131–5
   Web of Science ®Google Scholar
• Changqin H, Ying L. 2011. Quality control in pharmaceuticals: Residual solvents testing and analysis. In: Akyar I, ed. Wide spectra of quality control, InTech, 183–210. [Online] Available at: http://www.intechopen.com/books/wide-spectra-of-quality-control/quality-control-in-pharmaceuticals-residualsolvents-testing-and-analysis. Accessed 1 March 2014
   Google Scholar
• Choi SW, Kwon HY, Kim WS, Kim JH. Thermodynamic parameters on poly(D, L-lactide-co-glycolide) particle size in emulsification–diffusion process. Colloids Surf A, 2002;201:283–9
   Web of Science ®Google Scholar
• Davies OR, Lewis AL, Whitaker MJ, Tai H, Shakesheff KM, Howdle SM. Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv Drug Delivery Rev, 2008;60:373–87
   PubMed Web of Science ®Google Scholar
• Dijkhuizen-Radersma RV, Hesseling SC, Kaim PE, Groot KD, Bezemer JM. Biocompatibility and degradation of poly(ether-ester) microspheres: In vitro and in vivo evaluation. Biomaterials, 2002;23(24):4719–29
   PubMed Web of Science ®Google Scholar
• DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Health Econ, 2003;22(2):151–85
   PubMed Web of Science ®Google Scholar
• Dwivedi AM. Residual solvent analysis in pharmaceuticals. Pharm Tech, 2002;2002:42–6
   Google Scholar
• Falk RF, Randolph TW. Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly(L-lactide) microparticles. Pharm Res, 1998;15(8):1233–7
   PubMed Web of Science ®Google Scholar
• Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci, 2014;15:3640–59
   PubMed Web of Science ®Google Scholar
• Heller J. Biodegradable polymers in controlled drug delivery. Crit Rev Ther Drug Carrier Syst, 1984;1(1):39–90
   PubMedGoogle Scholar
• Heller J. Controlled drug release from poly(ortho esters) – A surface eroding polymer. J Control Release, 1985;2:167–77
   Google Scholar
• Heller J. Controlled release of biologically active compounds from bioerodible polymers. Biomaterials, 1980;1:51–7
   PubMed Web of Science ®Google Scholar
• Houchin ML, Topp EM. Physical properties of PLGA films during polymer degradation. J Appl Polym Sci, 2009;114:2848–54
   Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000;21:2475–90
   PubMed Web of Science ®Google Scholar
• Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microparticles: Problems associated with preparative techniques and release properties. J Microencapsul, 1990;7:297–325
   PubMed Web of Science ®Google Scholar
• Jeyanthi R, Thanoo BC, Metha RC, Deluca PP. Effect of solvent removal technique on the matrix characterstics of polylactide/glycolide microspheres for peptide delivery. J Control Release, 1996;38(2–3):235–44
   Web of Science ®Google Scholar
• Komen J, Groennendaal JW. 1991. Process of microencapsulation. US Patent No. 5066436
   Google Scholar
• Koushik K, Kompella UB. Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process. Pharma Res, 2004;21(3):524–35
   Google Scholar
• Kushwaha P. Organic volatile impurities: A regulatory overview. Pharma Times, 2012;44(5):25–30
   Google Scholar
• Lawter JR, Lanzilotti MG. 1992. Hardening agent for phase separation microencapsulation. European Patent Application, EP 0292710 A2
   Google Scholar
• Lewis DH, Sherman JD. 1989. Low residual solvent microspheres and microencapsulation process. PCT Patent No. WO 1989/003678
   Google Scholar
• Lewis DH. 1990. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin M, Langer R, eds. Biodegradable polymers as drug delivery systems. New York: Marcel Dekker, pp. 1–41
   Google Scholar
• Lu LC, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamada JA, Vacanti JP, Langer R, Mikos AG. In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials, 2000;21:1595–605
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel), 2011;3:1377–97
   PubMed Web of Science ®Google Scholar
• Michulec M, Wardenki W. Development of headspace solid-phase micro-extraction-gas chromatography method for the determination of solvent residues in edible oils and pharmaceuticals. J Chromatogr, 2005;1071:119–24
   PubMed Web of Science ®Google Scholar
• Middleton J. 2012. Tailoring of poly(lactide-co-glycolide) to control their properties for medical device and pharmaceutical. [Online] Available at: http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM335606.pdf. Accessed 3 August 2014
   Google Scholar
• Mullard A. 2011. FDA drug approvals. Nat Rev Drug Discov, 2012;1:91–4
   Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm, 1999;187:143–52
   PubMed Web of Science ®Google Scholar
• Nakano M, Ithoh M, Juni K, Sekikawa H, Arita T. Sustained urinary excretion of sulfamethizole following oral administration of enteric coated microcapsules in humans. Int J Pharm, 1980;4(4):291–8
   Google Scholar
• Nerlich B, Gustafsson J, Mank R, Horig J, Kochling W. 1993. Process for microencapsulation of water soluble drugs. Deutsche Patentschrift No. DE 4223169 C1
   Google Scholar
• Nihant N, Stassen S, Grandfils C, Jerome R, Teyssie Ph, Goffinet G. Microencapsulation by coacervation of poly(lactide-co-glycolide). III Characterization of the final microspheres. Polym Int, 1994;34:289–99
   Web of Science ®Google Scholar
• Nihant N, Stassen S, Grandfils C, Jerome R, Teyssie Ph. Microencapsulation by coacervation of poly(lactide-co-glycolide). II Encapsulation of a dispersed aqueous phase. Polym Int, 1993;32:171–6
   Web of Science ®Google Scholar
• Orsolini P, Mauvernay RY, Deghengi R. 1987. Microencapsulation by phase separation of water soluble medicaments. US Patent No. 4673595
   Google Scholar
• Orsolini P, Mauvernay RY, Deghengi R. 1986. Process for microencapsulation of water soluble drugs by phase separation. Deutsche Offenlegungsschrift Application, DE 3536902 A1
   Google Scholar
• Otero R, Carrera G. Static headspace gas chromatographic method for quantitative determination of residual solvents in pharmaceutical drug substances according to European Pharmacopoeia requirements. J Chromatogr A, 2004;1057:193–201
   PubMed Web of Science ®Google Scholar
• Perkins B, Pattanaik A. 2012. Emulsion method for preparing low residual solvent microparticles. US Patent Application, US 2012/0083444 A1
   Google Scholar
• Peterson H, Lambert O, Loeffler R, Ausborn M, Bonny J-D. 2007. Organic compounds. US Patent Application, US 2007/0122485 A1
   Google Scholar
• PRNewswire. 2011. Parenteral depots offer $8 billion of reformulation opportunities and a strong competitive edge in crowded pharmaceutical space. [Online] Available at: http://www.prnewswire.com/news-releases/parenteral-depots-offer-8-billion-of-reformulation-opportunities-and-a-strong-competitive-edge-in-crowded-pharmaceutical-space-116156554.html. Accessed 17 March 2014
   Google Scholar
• Quintanar-Guerrero D, Fessi H, Allemann E, Doelkar E. Influence of stabilizing agents and preparative variables on the formation of poly(D, L-lactic acid) nanoparticles by an emulsification–diffusion technique. Int J Pharm, 1996;143:133–41
   Web of Science ®Google Scholar
• Raiche AT, Perkins BH. 2013. Method for removing residual organic solvent from microparticles. European Patent Application, EP 2621473 A2
   Google Scholar
• Ramstack JM. 2005. Method for preparing microparticles using liquid–liquid extraction. US Patent No. 6884372 B2
   Google Scholar
• Rasal RM, Hirt DE. Toughness decrease of PLA-PHBHHx blend films upon surface confined photopolymerization. J Biomed Mater Res A, 2009;88A(4):1079–86
   Web of Science ®Google Scholar
• Rickey ME, Ramstack JM, Kumar R. 2009. Residual solvent extraction method and microparticles produced thereby. US Patent No. 7524530 B2
   Google Scholar
• Rickey ME, Ramstack M, Lewis DH, Mesens J. 1998. Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent. US Patent No. 5792477
   Google Scholar
• Rickey ME, Ramstack M, Lewis DH. 1999. Preparation of biodegradable, biocompatible microparticles containing a biologically active agent. US Patent No. 5916598
   Google Scholar
• Ruhe PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG. rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Jt Surg, 2003;85:75–81
   PubMed Web of Science ®Google Scholar
• Saez V, Hernandez JR, Peniche C. Microsphere as delivery system for the controlled release of peptide and proteins. Biotechnol Appl, 2007;24:108–16
   Google Scholar
• Song KC, Lee HS, Choung Y II, Cho KI, Ahn Y, Choi EJ. The effect of type of organic phase solvents on the particle size of poly(D,L -lactide-co-glycolide) nanoparticles. Colloids Surf A Physicochem Eng Asp, 2006;276:162–7
   Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkel HP, Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Delivery Rev, 2005;57:357–76
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia Convention. 2013. General chapters/chemical tests/<467> residual solvents. In: The United States Pharmacopeial Convention, ed. US Pharmacopeia 36 National Formulary 31, Volume 1. Maryland: United Book Press, pp. 195–207
   Google Scholar
• Thioune O, Fessi H, Devissaguet JP, Puisieux F. Preparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constant. Int J Pharm, 1997;146:233–8
   Web of Science ®Google Scholar
• Thomasin C, Johensen P, Alder R, Bemsel R, Hottinger G, Altorfer H, Wright AD, Wehrli E, Merkel HP, Gander B. A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. Eur J Pharm Biopharm, 1996;42:16–24
   Web of Science ®Google Scholar
• Thomasin C, Merkel HP, Gander BA. Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation. Int J Pharm, 1997;147:173–86
   Web of Science ®Google Scholar
• Thomasin C, Merkle HP, Gander B. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. J Pharm Sci, 1998b;87(3):269–75
   PubMed Web of Science ®Google Scholar
• Thomasin C, Nam-Tran H, Merkel HP, Gander B. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. J Pharm Sci, 1998a;87(3):259–68
   PubMed Web of Science ®Google Scholar
• Tice TR, Tabbi ES. 1991. Parenteral drug delivery: Injectables. In: Kydonieus A, ed. Treatise on controlled drug delivery: Fundamentals, optimization, applications. New York: Marcel Dekker, pp. 315–39
   Google Scholar
• Torza S, Mason SG. Three-phase interactions in shear and electrical fields. J Colloid Interface Sci, 1970;33(1):67–83
   Web of Science ®Google Scholar
• Van Krevelen DW. 1990. Properties of polymers, 3rd edn. Amsterdam: Elsevier, pp. 189–225, 287–320
   Google Scholar
• Vilos C, Velasquez LA. Therapeutic strategies based on polymeric microparticles. J Biomed Biotechnol, 2012;2012:1–9
   PubMedGoogle Scholar
• Wang HT, Palmer H, Linhardt RJ, Flanagan DR, Schmitt E. Degradation of poly(ester) microspheres. Biomaterials, 1990;11(9):679–68
   PubMed Web of Science ®Google Scholar
• Witschi C, Doelker E. Residual solvents in pharmaceutical products: Acceptable limits, influence on physicochemical properties, analytical methods and documented values. Eur J Pharm Biopharm, 1997;43(3):215–42
   Web of Science ®Google Scholar
• Wu XS. 1995a. Preparation, characterization and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszernski MJ Gresser JD, Schwartz ER, eds. Encyclopedic handbook of biomaterials and bioengineering. New York: Marcel Dekker, pp. 1151–250
   Google Scholar
• Wu XS. 1995b. Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszernski MJ, Gresser JD, Schwartz ER, eds. Encyclopedic handbook of biomaterials and bioengineering. New York: Marcel Dekker, pp. 1015–54
   Google Scholar
• Wu XS, Wang N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation. J Biomater Sci Polym, 2001;12:21–34
   PubMed Web of Science ®Google Scholar